Home›People›Anthony Caparso
AC

Anthony Caparso

President of SymKardia, Inc. and Nocionix, Inc.

ExecutiveDirectorRoles at 2 startups
Updated Nov 6, 2026·Latest SEC filing Nov 4, 2026·Suggest an edit

About Anthony Caparso

Anthony Caparso is president of SymKardia, Inc. in Westlake, Ohio. The company is developing a treatment for cardiac arrhythmias based on selective cardiac neuromodulation. He is also president of Nocionix, Inc., which has the same Westlake address, and he is a director of both companies.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Anthony Caparso in the role, so the role may have started earlier or lasted longer.

SymKardia, Inc. Current
President and director
2026 – Present · Westlake, OH
SymKardia is developing selective cardiac neuromodulation as a new way to treat patients with cardiac arrhythmias.
Nocionix, Inc. Current
President
Nocionix,Inc.
President and director
2026 · Westlake, OH
Nocionix develops a nerve-based therapy for people with chronic pain that avoids hormones, surgery, and opioids.

Key Colleagues at Startups

The people Anthony Caparso works with at each company, as listed on that company's latest Form D.

Nocionix,Inc. · Form D, Nov 4, 2026
RP
AS
Arun Sridhar
Director
CR
Claudio Rumazza
Executive officer and director
JB
TA
Tony Artiga
Director
SymKardia, Inc. · Form D/A, Oct 28, 2026
Bruce KenKnight
Bruce KenKnight
Chief Executive Officer
Steven Girouard
Steven Girouard
Executive officer
Jonathan Piccini
Jonathan Piccini
Executive officer
Imad Libbus
Imad Libbus
Chief Scientific Officer
Dwight Skinner
Dwight Skinner
Executive officer
RP
AS
Arun Sridhar
Director
CR
JB

Sources

  1. SECNocionix,Inc. Form D, filed Nov 4, 2026
  2. SECSymKardia, Inc. Form D/A, filed Oct 28, 2026
  3. companySymKardia company website